Trial Profile
A randomized, double-blind, placebo-controlled study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Tetrabenazine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 08 Jun 2011 New trial record